Editas Medicine Inc (EDIT): Eigentümerstruktur
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 6,1 US Dollar | 9 | 0 | 2 | 2 | 0 |
| #Shares | Short [%] | Short Ratio |
| 153.580.035 | 24,91 | 11,66 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Editas Medicine Inc
Mitarbeiter 87
Handelsplatz NASDAQ
Ticker Symbol EDIT
IPO Datum 2016-02-03
Adresse 11 Hurley Street, Cambridge, MA, United States, 02141
Webseite https://www.editasmedicine.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Gilmore O'Neill M.D. | President, CEO & Director |
| 2 | Ms. Amy Parison | Senior VP & CFO |
| 3 | Dr. Linda C. Burkly Ph.D. | Executive VP & Chief Scientific Officer |
| 4 | Dr. Feng Zhang Ph.D. | Co-Founder & Scientific Advisory Board Member |
| 5 | Dr. George McDonald Church Ph.D. | Co-Founder & Scientific Advisory Board Member |
| 6 | Mr. Gregory Whitehead | Executive VP and Chief Technical & Quality Officer |
| 7 | Mr. Damien Grierson J.D. | Senior VP, General Counsel & Corporate Secretary |
| 8 | Mr. Tom Love | Vice President of People |
| 9 | Mr. Frank Panaccio | Senior VP & Chief Business Officer |
| 10 | Ms. Brieana Buckley | Senior Vice President of Development and Program Leadership |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | TCG Crossover Management, LLC | 7,23% | 32,78 Mio. USD |
| 2 | BlackRock Inc | 6,90% | 31,24 Mio. USD |
| 3 | COMMODORE CAPITAL LP | 5,79% | 26,22 Mio. USD |
| 4 | RA Capital Management, LLC | 5,79% | 26,22 Mio. USD |
| 5 | ADAR1 Capital Management LLC | 5,79% | 26,22 Mio. USD |
| 6 | Vanguard Capital Management, LLC | 4,00% | 18,12 Mio. USD |
| 7 | Paradigm Biocapital Advisors LP | 3,64% | 16,48 Mio. USD |
| 8 | Opaleye Management Inc | 2,51% | 11,39 Mio. USD |
| 9 | Vanguard Portfolio Management, LLC | 2,34% | 10,62 Mio. USD |
| 10 | Woodline Partners LP | 2,32% | 10,49 Mio. USD |
| 11 | Vivo Capital, LLC | 2,31% | 10,49 Mio. USD |
| 12 | GordonMD Global Investments LP | 2,04% | 9,23 Mio. USD |
| 13 | The Goldman Sachs Group Inc | 1,70% | 7,71 Mio. USD |
| 14 | Geode Capital Management, LLC | 1,67% | 7,58 Mio. USD |
| 15 | Renaissance Technologies Corp | 1,61% | 7,28 Mio. USD |
| 16 | Logos Global Management LP | 1,45% | 6,56 Mio. USD |
| 17 | State Street Corp | 1,43% | 6,47 Mio. USD |
| 18 | Marshall Wace Asset Management Ltd | 1,33% | 6,01 Mio. USD |
| 19 | D. E. Shaw & Co LP | 1,24% | 5,61 Mio. USD |
| 20 | JPMorgan Chase & Co | 1,21% | 5,49 Mio. USD |